Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Murphy

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Plos One|January 24, 2014
HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional studyJohannes S Gach, Chad J Achenbach, Veronika Chromikova, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2019
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosisElina Berliba, Maxim Bogus, Frédéric Vanhoutte, et al.
The Journal of Infectious Diseases|October 10, 2020
Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell ModulationCarolyn A Luscombe, Anchalee Avihingsanon, Khuanchai Supparatpinyo, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2023
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban TanzaniaEn-Ling Wu, Beatrice Christian, Adovich S Rivera, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2010
Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trialBabafemi O Taiwo, John A Idoko, Anne-Geneviève Marcelin, et al.
Journal of Virology|October 29, 2003
Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDSAsa Ohagen, Amy Devitt, Kevin J Kunstman, et al.
Cureus|March 13, 2026
High-Risk Human Papillomavirus and Other Sexually Transmitted Infections Among Women Living With Human Immunodeficiency Virus in Jos, NigeriaNanma T Cosmas, Francis A Magaji, Shedrach Y Acheng, et al.
The Journal of Infectious Diseases|March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2aJonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Antiviral Therapy|October 1, 2004
Potent antiviral effect of reverset in HIV-1-infected adults following a single oral doseLieven J Stuyver, Tamara R McBrayer, Dirk Schürmann, et al.
Journal of Global Health|April 13, 2023
Sustaining the momentum for global cancer research and career development in the COVID-19 era: Lessons and challengesJonah Musa, Francis A Magaji, Maryam J Ali, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Plos One|January 24, 2014
HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional studyJohannes S Gach, Chad J Achenbach, Veronika Chromikova, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2019
Safety, pharmacokinetics and antiviral activity of AT-527, a novel purine nucleotide prodrug, in HCV-infected subjects with and without cirrhosisElina Berliba, Maxim Bogus, Frédéric Vanhoutte, et al.
The Journal of Infectious Diseases|October 10, 2020
Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell ModulationCarolyn A Luscombe, Anchalee Avihingsanon, Khuanchai Supparatpinyo, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2023
Renal outcomes in adults with HBV, HIV and HBV/HIV coinfection after 3 years of antiviral therapy in urban TanzaniaEn-Ling Wu, Beatrice Christian, Adovich S Rivera, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 22, 2010
Patient-selected treatment partners did not protect against drug resistance during first-line NNRTI-based HAART in a randomized trialBabafemi O Taiwo, John A Idoko, Anne-Geneviève Marcelin, et al.
Journal of Virology|October 29, 2003
Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDSAsa Ohagen, Amy Devitt, Kevin J Kunstman, et al.
Cureus|March 13, 2026
High-Risk Human Papillomavirus and Other Sexually Transmitted Infections Among Women Living With Human Immunodeficiency Virus in Jos, NigeriaNanma T Cosmas, Francis A Magaji, Shedrach Y Acheng, et al.
The Journal of Infectious Diseases|March 29, 2012
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2aJonathan J Hubbard, Teresa Greenwell-Wild, Lisa Barrett, et al.
Antiviral Therapy|October 1, 2004
Potent antiviral effect of reverset in HIV-1-infected adults following a single oral doseLieven J Stuyver, Tamara R McBrayer, Dirk Schürmann, et al.
Journal of Global Health|April 13, 2023
Sustaining the momentum for global cancer research and career development in the COVID-19 era: Lessons and challengesJonah Musa, Francis A Magaji, Maryam J Ali, et al.
Pageof 18